Katherine Collins Overview
- Investor Type
-
Angel
- Investments
-
3
- Exits
-
2

Katherine Collins General Information
Description
Ms. Katherine Collins serves as Head of Sustainable Investing at Putnam Investments. Ms. Collins also served as Board Member at Finomial. She is an Angel Investor. She is an Advisor in BVC Partners.She is an Angel Investor. She is also the Founder and serves as Chief Executive Officer at Honeybee Capital. She also serves as an Investment Committee Member at Belle Capital. Ms. Collins is dedicated to the belief that pollinating ideas across varied fields leads to optimal investment decision making. Following a long and successful career in traditional equity management, Katherine set out to re-integrate her investment philosophy with the broader world, traveling as a pilgrim and volunteer, earning her MTS degree at Harvard Divinity School, and following lessons from the natural world to focus on investing as a valued and integrated profession, beneficial to our communities and our planet. Prior to founding Honeybee, Ms. Collins served in numerous capacities for Fidelity Management and Research Company: as head of US Equity Research, she led one of the largest buy-side research operations in the world. As Portfolio Manager, she was solely responsible for investment decisions for the multi-billion dollar Fidelity America funds while based in London, and for the entire range of Fidelity Mid-Cap Funds while based in Boston. Every fund that Ms. Collins managed at Fidelity outperformed its relevant benchmark during her tenure. As Analyst, she managed several different industry-specific funds and researched over a dozen different industries. Ms. Collins also spent two years at the Fidelity Foundations, acting as Program Officer for these large philanthropic organizations. She holds degrees from Wellesley College and Harvard University.
Business Details
Primary Investor Type
Corporate Office
- P.O. Box 219697
- 430 West 7th Street Suite 219697
- Kansas City, MO 64121-9697
- United States
Katherine Collins Investments (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Alladapt Immunotherapeutics | 19-Feb-2020 | Later Stage VC | Drug Discovery | Bankruptcy: Liquidation | ||
Alladapt Immunotherapeutics | 20-Mar-2018 | Drug Discovery | Bankruptcy: Liquidation | |||
SpoonfulONE | 05-Oct-2016 | Food Products | Generating Revenue |
Katherine Collins Exits (2)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Alladapt Immunotherapeutics | 23-Jul-2024 | Bankruptcy: Liquidation | |
SpoonfulONE | 01-Jan-2022 |
Katherine Collins Investments by Industry, Year, and Region
Katherine Collins FAQs
-
Who is Katherine Collins?
Katherine Collins is an angel Investor who has made 3 investments.
-
What kind of investor is Katherine Collins?
Katherine Collins is an angel investor.
-
What does Katherine Collins do?
As an angel investor, Katherine Collins invests personal money into promising companies, typically in exchange for equity.
-
What has Katherine Collins invested in?
Katherine Collins has made numerous investments in companies like Alladapt Immunotherapeutics and SpoonfulONE within the Drug Discovery and Food Products industries.
-
What has Katherine Collins invested in recently?
Katherine Collins's latest investment was on 19-Feb-2020 in Alladapt Immunotherapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »